RBC Capital Sticks to Its Hold Rating for PTC Therapeutics (PTCT)

TipRanks09:45

Form 144 | PTC Therapeutics(PTCT.US) Director Proposes to Sell 764.77K in Common Stocks

SEC FILLINGS DISCLOSED/ May 22, $PTC Therapeutics(PTCT.US)$ Director ZELDIS JEROME B intends to sell 20,000 shares of its common stock on May 22, with a total market value of approximately $764.77K.

Futu NewsMay 22 22:15

Analysts' Revenue Estimates For PTC Therapeutics, Inc. (NASDAQ:PTCT) Are Surging Higher

PTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The consensus estimated revenue

Simply Wall StMay 22 18:49

Hold Rating on PTC Therapeutics Amid Regulatory Uncertainty for Translarna

TipRanksMay 22 12:55

PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

Yahoo FinanceMay 22 00:26

PTC Therapeutics Price Target Raised to $53.00/Share From $43.00 by JP Morgan

PTC Therapeutics Price Target Raised to $53.00/Share From $43.00 by JP Morgan

Dow JonesMay 22 00:17